GeneDx Holdings Corp. Class A WGS 深 沪
等待开盘 02-03 09:30:00 美东时间
99.01
+2.750
+2.86%
华盛通- 最 高101.50
- 今 开96.86
- 成交量 57.51万股
- 最 低 96.50
- 昨 收 96.26
- 总市值 28.62亿
- 52周最高 170.87
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 55.17
- 委 比 -71.04%
- 总股本 2890.46万
- 历史最高 896.94
- 量 比 0.89
- 振 幅 5.19%
- 历史最低 2.466
- 每 手 1
- 风险率 27.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多GeneDx Holdings shares are trading lower. The company narrowed its FY25 sales guidance and issued FY26 sales guidance above estimates.
GeneDx Holdings shares are trading lower. The company narrowed its FY25 sales g...
01-13 04:32
GeneDx Holdings Narrows FY2025 Sales Guidance from $425.000M-$428.000M to $427.000M vs $426.934M Est
GeneDx Holdings (NASDAQ:WGS) narrows FY2025 sales outlook from $425.000 million-$428.000 million to $427.000 million vs $426.934 million estimate.
01-12 20:54
GeneDx Holdings Sees Q4 Sales $121.000M vs $120.373M Est
GeneDx Holdings (NASDAQ:WGS) sees Q4 sales of $121.000 million vs $120.373 million analyst estimate.
01-12 20:53
GeneDx Holdings Sees FY2026 Sales $540.000M-$555.000M vs $529.130M Est
GeneDx Holdings (NASDAQ:WGS) sees FY2026 sales of $540.000 million-$555.000 million vs $529.130 million analyst estimate.
01-12 20:53
GeneDx appoints Dr. Linda Genen as CMO
GeneDx (NASDAQ:WGS) on Tuesday stated the appointment of Linda Genen, MD, MPH, as Chief Medical Officer. Genen brings decades of leadership across clinical care, payer strategy, innovation, and matern...
01-06 21:48
美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
2025-12-23 12:32
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
GeneDx's GUARDIAN Study Honored By JAMA For Demonstrating Genomic Newborn Screening Can Detect Serious Childhood Conditions Missed By Traditional Methods
Prestigious recognition underscores the impact of large-scale genomic screening in identifying serious childhood genetic conditions in conjunction with traditional newborn screeningGeneDx (NASDAQ:WGS), a leader in
2025-12-15 21:55
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
2025-12-15 15:30
